New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 3, 1998, Pages 292-296

  Shanson, D C ^a  

^a Unilabs   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; FLUCLOXACILLIN; GENTAMICIN; PENICILLIN G; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; DRUG CHOICE; ENTEROCOCCUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; SHORT SURVEY; STAPHYLOCOCCUS; STREPTOCOCCUS; UNITED KINGDOM;

AMERICAN HEART ASSOCIATION; ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; UNITED STATES;

EID: 0031659215     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.3.292     Document Type: Short Survey

References (26)

1. Working Party Report of the British Society for Antimicrobial Chemotherapy. (1998). Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 79, 207-10.
2. Wilson, W. R., Karchmer, A. W., Dajani, A. J., Taubert, K. A., Bayer, A., Kaye, D. et al. (1995). Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. Journal of the American Medical Association 274, 1706-13.
3. Durack, D. T., Lukes, A. S., Bright, D. K. & the Duke Endocarditis Service. (1994). New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. American Journal of Medicine 96, 200-9.
4. Lamas, C. C. & Eykyn, S. J. (1997). Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clinical Infectious Diseases 25, 713-9.
5. Working Party Report of the British Society for Antimicrobial Chemotherapy. (1985). Antibiotic treatment of streptococcal and staphylococcal endocarditis. Lancet ii, 815-7.
6. Shanson, D. C. (1981). Short-course treatment of streptococcal endocarditis. Journal of Antimicrobial Chemotherapy 8, 427-8.
7. Fantin, B. & Carbon, C. (1992). In vivo antibiotic synergism: contribution of animal models. Antimicrobial Agents and Chemotherapy 36, 907-12.
8. Karchmer, A. W. (1988). Antibiotic therapy of nonenterococcal streptococcal and staphylococcal endocarditis: current regimens and some future considerations. Journal of Antimicrobial Chemotherapy 21, Suppl. C, 91-106.
9. Roberts, S. A., Lang, S. D. R. & Ellis-Pegler, S. B. (1993). Short-course treatment of penicillin susceptible viridans streptococcal infective endocarditis with penicillin and gentamicin. Infectious Diseases Clinical Practice 2, 191-4.
10. Francioli, P., Ruch, W., Stamboulian, D. & the International Infective Endocarditis Study Group. (1995). Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clinical Infectious Diseases 21, 1406-10.
11. Etienne, J., Brun, Y., El Solh, N., Delorme, V., Mouren, C., Bes, M. & Fleurette, J. (1988). Characterisation of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditis. Journal of Clinical Microbiology 26, 613-7.
12. Levine, D. P., Fromm, B. S. & Reddy, B. R. (1991). Slow response to vancomycin or vancomycin plus rifampicin in methicillin resistant Staphylococcus aureus endocarditis. Annals of Internal Medicine 115, 674-80.
13. Karchmer, A. W. & Gibbons, G. W. (1994). Infections of prosthetic heart valves and vascular grafts. In Infections Associated with Indwelling Medical Devices, 2nd edn (Bisno, A. L. & Waldvogel, F. A., Eds), pp. 213-49. American Society for Microbiology, Washington, DC.
14. Eliopoulos, G. M. (1993). Aminoglycoside resistant enterococcal endocarditis. Medical Clinics of North America 17, 117-33.
15. Harley, W. B. & Stratton, C. W. (1993). The serum bactericidal tests revisited. Infectious Disease Newsletter 12, 61-4.
16. Eykyn, S. J. (1987). The role of the laboratory is assisting treatment - a review of current UK practices. Journal of Antimicrobial Chemotherapy 20, Suppl. A, 51-64.
17. MacGowan, A. M., McMullin, C., James, P., Bowker, K., Reeves, D. & White, L. (1997). External quality assessment of the serum bactericidal test: results of a methodology/ interpretation questionnaire. Journal of Antimicrobial Chemotherapy 39, 277-84.
18. Wilson, A. P. R. & Gaya, H. (1996). Treatment of endocoarditis with teicoplanin: a retrospective analysis of 104 cases. Journal of Antimicrobial Chemotherapy 38, 507-21.
19. Gilbert, D. N., Wood, C. A., Kimbrough, R. C. & the Infectious Diseases Consortium of Oregon. (1991). Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. Antimicrobial Agents and Chemotherapy 35, 79-87.
20. Bayer, A. S. (1993). Infective endocarditis. Clinical Infectious Diseases 17, 313-22.
21. Wilson, A. P., Grüneberg, R. N. & Neu, H. (1993). Dosage recommendations for teicoplanin. Journal of Antimicrobial Chemotherapy 32, 792-6.
22. Rybak, M. J., Lerner, S. A., Levine, D. P., Albrecht, L. M., McNeil, P. L., Thompson, G. A. et al. (1991). Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrobial Agents and Chemotherapy 35, 696-700.
23. Bannerman, T. L., Wadiak, D. L. & Kloos, W. E. (1991). Susceptibility of staphylococcal species and subspecies to teicoplanin. Antimicrobial Agents and Chemotherapy 35, 1919-22.
24. Felmingham, D. (1993). Towards the ideal glycopeptide. Journal of Antimicobial Chemotherapy 32, 663-6.
25. Nahass, R. G., Weinstein, M. P., Bartels, J. & Gocke, D. J. (1990). Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and positive patients. Journal of Infectious Diseases 162, 967-70.
26. Francioli, P. B. (1993). Ceftriaxone and outpatient treatment of infective endocarditis. Infectious Disease Clinics of North America 17, 97-115.